Alnylam Uncovers Genetic Mutations in INHBE That Protect Against Abdominal Obesity
– Publication in Nature Communications Reports that People with Loss of Function Mutations in the INHBE Gene Have Reduced Abdominal Fat, a Favorable Metabolic Profile, and are at Lower Risk of Cardiovascular Disease and Type 2 Diabetes – – Alnylam to Pursue INHBE as a Therapeutic Target for Cardiometabolic Disease – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, … [Read more…]
